The Angina Market, which was worth USD 9.56 billion in 2022, is expected to grow to USD 13.66 billion by 2029, at a steady 5.23% CAGR. Angina, caused by insufficient blood flow to the heart muscles, causes chest pain or discomfort. This condition is frequently caused by narrowed arteries that prevent oxygen-rich blood flow. Coronary artery spasm, unstable plaques, decreased heart pumping function, and blood clots are all culprits. Chest pain, shortness of breath, weakness, nausea, and dizziness are all symptoms. Treatment includes lifestyle changes, as well as medications such as beta-blockers, NSAIDs, ACE inhibitors, and calcium channel blockers, which help with symptom relief in mild to severe cases.
Angina Market Report Scope and Research Methodology
MMR published a Angina Market report to help clients understand future product demand by providing valuable insights into the global Angina industry. The report synopsis provides detailed information on market size, growth factors, statistics, key players, and a comprehensive regional and national market scenario.
The Angina market report provides in-depth information on sales, revenue, product types, applications, and key players. It makes use of primary and secondary research, segmentation, and various forecasting methods. PESTEL analysis examines micro and macroeconomic factors, whereas SVOR analysis estimates new opportunities, strengths, and risks. The Porter Five Forces model examines key players and market competition.
Simply Click Here To Buy Full Report @ https://www.maximizemarketresearch.com/request-sample/221908
Angina Market Regional Insights
The report compares market size, Angina growth rate, and import-export across the following regions: North America, Europe, Asia Pacific, South America, the Middle East, and Africa.
Angina Market Segmentation
Beta Blockers are poised to demonstrate a substantial Compound Annual Rate (CAR) during the forecast period. Operating by impeding the impact of adrenaline on the heart, beta-blockers confer advantages such as decelerating heart rate and diminishing the force of heart muscle contraction. For individuals with stable angina attributed to coronary artery disease (CAD), beta-blockers are regarded as the primary therapeutic approach. The growth of this segment primarily stems from an increase in the target population and a growing number of strategic initiatives among market participants to enhance the commercial availability of beta-blocker medications. For instance is the agreement between New American Therapeutics and Melinta Therapeutics in April 2022, granting the rights to TOPROL-XL (metoprolol succinate) in the United States. TOPROL-XL, an FDA-approved cardio-selective beta-blocker, is utilized for hypertension treatment, either independently or in combination with other antihypertensives. It is also employed for the long-term treatment of angina pectoris and stable, symptomatic heart failure due to specific causes. Such collaborations and advancements are expected to strengthen the growth of the beta-blockers segment of Angina Market during the forecast period.
Interested to Procure the Data? Inquire Sample Here @ https://www.maximizemarketresearch.com/request-sample/221908
by Drug Class
Beta blockers
Nitrates & Calcium Channel Blockers
Angiotensin-converting Enzyme Inhibitors
Others
by End User
Hospitals
Cardiology Centers
Others
Angina Market Key Players
1. Sanofi
2. Pfizer
3. Otsuka Pharmaceutical Co., Ltd.
4. Novartis AG
5. Merck & Co., Inc.
6. Gilead Sciences, Inc.
7. Amgen Inc.
8. Eli Lilly and Company
9. GlaxoSmithKline
10. Axus Cardium Pharmaceuticals
11. LegoChem Biosciences
12. Lee’s Pharmaceutical Holdings
13. Milestone Pharmaceuticals
14. Juventas Therapeutics
15. ViroMed
Download an Illustrative overview: https://www.maximizemarketresearch.com/request-sample/221908
About Maximize Market Research:
Maximize Market Research is a market research and consulting firm with professionals from various industries. Medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems are among the industries we cover. We offer market-verified industry estimates, technical trend analysis, critical market research, strategic advice, competition analysis, production and demand analysis, and client impact studies, to name a few.